VIDEO DOI: https://doi.org/10.48448/emqj-ea72
July 11, 2022
Atlanta, United States
The effects of diabetes and glycemic control on cancer outcomes in individuals with metastatic breast cancer
Next from ENDO 2022
The Dramatic Fat Mass Loss Caused by Bimagrumab is Similar in Diabetic and Non-diabetic Patients.
11 July 2022